- 大部份公司都有淡旺季, 所以通常是看年增率
- 如果是成長期(在炒新的成長動能)的公司或景氣從谷底翻揚, 就可以觀察月增率
- 漲很多的股票要留意營收年增率或月增率大幅減少, 又或者是合約負債已經開始減少
- 留意短期平均營收向上或向下穿越長期平均營收
- 觀察累計營收年增率的累計增加或虧損收斂
年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
---|---|---|---|---|---|---|---|---|---|---|
2024/10 | 5.49 | 16.73 | 39.15 | 40.42 | -5.34 | 14.71 | N/A | - | ||
2024/9 | 4.7 | 3.79 | 20.36 | 34.94 | -9.86 | 13.63 | 0.48 | - | ||
2024/8 | 4.53 | 2.97 | -14.89 | 30.24 | -13.25 | 13.63 | 0.48 | - | ||
2024/7 | 4.4 | -6.55 | 1.74 | 25.71 | -12.95 | 12.16 | 0.54 | - | ||
2024/6 | 4.71 | 54.06 | 8.53 | 21.31 | -15.47 | 12.06 | 0.5 | - | ||
2024/5 | 3.05 | -28.94 | -22.71 | 16.61 | -20.46 | 10.39 | 0.57 | - | ||
2024/4 | 4.3 | 41.6 | 16.91 | 13.55 | -19.94 | 9.85 | 0.61 | - | ||
2024/3 | 3.04 | 20.5 | -36.49 | 9.25 | -30.16 | 9.25 | 0.4 | - | ||
2024/2 | 2.52 | -31.91 | -39.34 | 6.22 | -26.59 | 11.21 | 0.33 | - | ||
2024/1 | 3.7 | -25.89 | -14.33 | 3.7 | -14.33 | 13.12 | 0.28 | - | ||
2023/12 | 4.99 | 12.88 | -0.95 | 52.12 | -1.98 | 13.36 | 0.28 | - | ||
2023/11 | 4.42 | 12.17 | -20.93 | 47.13 | -2.09 | 12.27 | 0.3 | - | ||
2023/10 | 3.94 | 0.97 | -28.04 | 42.71 | 0.38 | 13.17 | 0.28 | - | ||
2023/9 | 3.9 | -26.61 | -27.71 | 38.76 | 4.59 | 13.55 | 0.43 | - | ||
2023/8 | 5.32 | 23.11 | -10.78 | 34.86 | 10.1 | 13.98 | 0.42 | - | ||
2023/7 | 4.32 | -0.31 | -9.48 | 29.54 | 14.95 | 12.61 | 0.47 | - | ||
2023/6 | 4.34 | 9.7 | -5.54 | 25.22 | 20.53 | 11.96 | 0.45 | - | ||
2023/5 | 3.95 | 7.49 | -10.71 | 20.88 | 27.86 | 12.41 | 0.44 | - | ||
2023/4 | 3.68 | -23.08 | -1.48 | 16.93 | 42.2 | 12.61 | 0.43 | - | ||
2023/3 | 4.78 | 15.1 | 55.84 | 13.25 | 62.16 | 13.25 | 0.48 | 主要係因越南地區子公司之客戶需求較高所致 | ||
2023/2 | 4.15 | -3.84 | 95.39 | 8.47 | 65.96 | 13.51 | 0.47 | 主係因客戶對本集團之產品需求增加所致 | ||
2023/1 | 4.32 | -14.31 | 44.96 | 4.32 | 44.96 | 14.95 | 0.43 | - | ||
2022/12 | 5.04 | -9.89 | 26.4 | 53.18 | 24.53 | 16.11 | 0.5 | - | ||
2022/11 | 5.59 | 2.08 | 60.91 | 48.14 | 24.33 | 16.48 | 0.49 | 本月較去年本月營收增加60.92%,主要係因去年本集團中國子公司部分產品生命週期結束所致 | ||
2022/10 | 5.48 | 1.43 | 51.7 | 42.54 | 20.72 | 16.85 | 0.48 | 主係因去年度本集團部分產品生命週期結束所致 | ||
2022/9 | 5.4 | -9.42 | 78.44 | 37.06 | 17.18 | 16.14 | 0.66 | 主要係因去年本月本集團在越南之子公司尚未開始量產所致 | ||
2022/8 | 5.96 | 24.9 | 103.58 | 31.66 | 10.69 | 15.33 | 0.7 | 本月較去年營收增加逾100%主要係因本公司越南子公司量產逐漸增加而去年本月越南子公司尚未進入量產所致 | ||
2022/7 | 4.77 | 4.03 | 54.12 | 25.7 | 0.09 | 13.79 | 0.78 | 本月較去年本月營收增加54%,主要係因去年本月本集團在越南之子公司尚未開始量產且中國子公司部分產品生命週期結束所致 | ||
2022/6 | 4.59 | 3.69 | 31.54 | 20.92 | -7.32 | 12.75 | 0.99 | - | ||
2022/5 | 4.43 | 18.6 | 5.59 | 16.33 | -14.42 | 11.23 | 1.13 | - | ||
2022/4 | 3.73 | 21.66 | -10.35 | 11.9 | -20.06 | 8.92 | 1.42 | - | ||
2022/3 | 3.07 | 44.31 | -11.09 | 8.17 | -23.82 | 8.17 | 1.41 | - | ||
2022/2 | 2.13 | -28.66 | -29.48 | 5.1 | -29.86 | 9.09 | 1.27 | - | ||
2022/1 | 2.98 | -25.29 | -30.13 | 2.98 | -30.13 | 10.44 | 1.11 | - | ||
2021/12 | 3.99 | 14.71 | -12.59 | 42.7 | -11.94 | 11.08 | 1.03 | - | ||
2021/11 | 3.48 | -3.76 | -33.37 | 38.72 | -11.87 | 10.12 | 1.13 | - | ||
2021/10 | 3.61 | 19.31 | -16.22 | 35.24 | -8.97 | 9.57 | 1.19 | - | ||
2021/9 | 3.03 | 3.33 | -37.35 | 31.63 | -8.06 | 9.06 | 1.05 | - | ||
2021/8 | 2.93 | -5.43 | -34.77 | 28.6 | -3.28 | 9.52 | 1.0 | - | ||
2021/7 | 3.1 | -11.21 | -20.61 | 25.67 | 2.35 | 10.78 | 0.89 | - | ||
2021/6 | 3.49 | -16.76 | -9.03 | 22.57 | 6.58 | 11.84 | 0.43 | - | ||
2021/5 | 4.19 | 0.69 | 23.87 | 19.08 | 10.03 | 11.81 | 0.44 | - | ||
2021/4 | 4.16 | 20.65 | 6.64 | 14.89 | 6.68 | 10.63 | 0.48 | - | ||
2021/3 | 3.45 | 14.46 | -12.83 | 10.73 | 6.69 | 10.73 | 0.34 | - | ||
2021/2 | 3.01 | -29.3 | 124.18 | 7.28 | 19.38 | 11.84 | 0.31 | 主係因109年度受疫情影響復工延遲,致營收下降 | ||
2021/1 | 4.26 | -6.53 | -10.06 | 4.26 | -10.06 | 14.04 | 0.26 | - | ||
2020/12 | 4.56 | -12.55 | -7.14 | 48.5 | -15.58 | 14.09 | 0.23 | - | ||
2020/11 | 5.22 | 21.01 | 12.59 | 43.93 | -16.37 | 14.36 | 0.23 | - | ||
2020/10 | 4.31 | -10.78 | -1.2 | 38.72 | -19.17 | 13.64 | 0.24 | - | ||
2020/9 | 4.83 | 7.58 | -4.32 | 34.4 | -20.97 | 13.23 | 0.25 | - | ||
2020/8 | 4.49 | 15.1 | -4.34 | 29.57 | -23.16 | 12.23 | 0.28 | - | ||
2020/7 | 3.9 | 1.73 | -6.24 | 25.08 | -25.77 | 11.12 | 0.3 | - | ||
2020/6 | 3.84 | 13.34 | -11.02 | 21.18 | -28.51 | 11.12 | 0.27 | - | ||
2020/5 | 3.38 | -13.3 | -41.08 | 17.34 | -31.49 | 11.25 | 0.27 | - | ||
2020/4 | 3.9 | -1.38 | -26.39 | 13.96 | -28.67 | 9.21 | 0.33 | - | ||
2020/3 | 3.96 | 194.4 | -30.89 | 10.05 | -29.52 | 10.04 | 0.36 | - | ||
2020/2 | 1.34 | -71.64 | -63.4 | 6.1 | -28.61 | 11.0 | 0.33 | 受到肺炎疫情影響,配合當地政府延後開工所致 | ||
2020/1 | 4.74 | -3.51 | -2.58 | 4.74 | -2.58 | 14.29 | 0.25 | - | ||
2019/12 | 4.91 | 6.02 | 3.73 | 57.45 | 28.64 | 0.0 | N/A | - | ||
2019/11 | 4.63 | 6.17 | -11.31 | 52.53 | 31.59 | 0.0 | N/A | - |
年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 |
---|---|---|---|---|---|---|---|---|---|
2024/1 | 3.7 | 2023/1 | 4.32 | 2022/1 | 2.98 | 2021/1 | 4.26 | 2020/1 | 4.74 |
2024/2 | 2.52 | 2023/2 | 4.15 | 2022/2 | 2.13 | 2021/2 | 3.01 | 2020/2 | 1.34 |
2024/3 | 3.04 | 2023/3 | 4.78 | 2022/3 | 3.07 | 2021/3 | 3.45 | 2020/3 | 3.96 |
2024/4 | 4.3 | 2023/4 | 3.68 | 2022/4 | 3.73 | 2021/4 | 4.16 | 2020/4 | 3.9 |
2024/5 | 3.05 | 2023/5 | 3.95 | 2022/5 | 4.43 | 2021/5 | 4.19 | 2020/5 | 3.38 |
2024/6 | 4.71 | 2023/6 | 4.34 | 2022/6 | 4.59 | 2021/6 | 3.49 | 2020/6 | 3.84 |
2024/7 | 4.4 | 2023/7 | 4.32 | 2022/7 | 4.77 | 2021/7 | 3.1 | 2020/7 | 3.9 |
2024/8 | 4.53 | 2023/8 | 5.32 | 2022/8 | 5.96 | 2021/8 | 2.93 | 2020/8 | 4.49 |
2024/9 | 4.7 | 2023/9 | 3.9 | 2022/9 | 5.4 | 2021/9 | 3.03 | 2020/9 | 4.83 |
2024/10 | 5.49 | 2023/10 | 3.94 | 2022/10 | 5.48 | 2021/10 | 3.61 | 2020/10 | 4.31 |
N/A | N/A | 2023/11 | 4.42 | 2022/11 | 5.59 | 2021/11 | 3.48 | 2020/11 | 5.22 |
N/A | N/A | 2023/12 | 4.99 | 2022/12 | 5.04 | 2021/12 | 3.99 | 2020/12 | 4.56 |
- 每季的合約負債通常會反應在未來半年到一年後的營收
合約負債 QoQ YoY | |||
---|---|---|---|
24Q3 (20) | 0.15 | -83.87 | -79.45 |
24Q2 (19) | 0.93 | -15.45 | 60.34 |
24Q1 (18) | 1.1 | 61.76 | 86.44 |
23Q4 (17) | 0.68 | -6.85 | 13.33 |
23Q3 (16) | 0.73 | 25.86 | 30.36 |
23Q2 (15) | 0.58 | -1.69 | 65.71 |
23Q1 (14) | 0.59 | -1.67 | 0 |
22Q4 (13) | 0.6 | 7.14 | -6.25 |
22Q3 (12) | 0.56 | 60.0 | 0 |
22Q2 (11) | 0.35 | 0 | 94.44 |